Integrity Implants and Fusion Robotics have merged to form Accelus, which plans to accelerate the adoption of minimally invasive surgery as the standard of care in spine.
Accelus aims to address cost and efficiency drawbacks of robotic spine surgery to accelerate the technology's adoption in both hospitals and ASCs, according to a July 6 news release.
"Fusion Robotics and Integrity Implants have built enabling technology platforms that create a force multiplier for spinal care," said Chris Walsh, who will serve as CEO of Accelus. "Our products and culture create accessibility to fit each patient's anatomy, each surgeon's preferred approach and each healthcare facility's space and budget limitations."
Integrity Implants' flagship product, the FlareHawk lumbar interbody fusion device, received FDA clearance in 2016 and CE mark approval in 2021. More than 10,500 devices have been implanted in over 8,000 patients, the company said.
Fusion Robotics received FDA clearance for its initial system in February.
Accelus' corporate offices, research and development, distribution and surgeon training facility will be headquartered in Palm Beach Gardens, Fla. Further surgeon training labs and R&D centers will be located in Boulder, Colo., and San Diego.